Avita Medical | 1811094D - Gross Profit On Sales


Avita Medical reported AUD14.31M in Gross Profit on Sales for its fiscal semester ending in December of 2025.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
Celltrion KRW 39.29B 7.7B Mar/2026
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Cochlear AUD 856.8M 430M Dec/2025
CSL USD 4.46B 2.71B Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Mayne Pharma AUD 86.13M 18.92M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Nanosonics AUD 78.01M 3.95M Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organigram Holdings CAD 16.41M 6.91M Mar/2026
Pacific Edge NZD 5.2M 1.75M Jun/2024
Pharma Mar EUR 44.87M 5.63M Jun/2026
Polynovo AUD 61.26M 38M Dec/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Qiagen NV USD 340.39M 30.78M Jun/2026
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 890.98M 4.45M Mar/2026
Sartorius EUR 433.1M 18.6M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Telix Pharmaceuticals AUD 260.35M 42.53M Jun/2026
Tilray USD 57.47M 10.16M Jun/2025
Zealand Pharma A/S 34M 34.92M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026